ليست عنوان مقالات لاتين Neurological deficit as the first manifestation of vesical transitional cell carcinoma Neurotic butterflies in my stomach: The role of anxiety, anxiety sensitivity and depression in functional gastrointestinal disorders

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Neurological deficit as the first manifestation of vesical transitional cell carcinoma

2

neurological deficit following combined spinal-Epidural Anesthesia for knee arthroplasty

3

Neurological Disorders and Oxidative Toxic Stress: A Role of Metal Nanoparticles

4

Neurological disorders and the structure of human consciousness

5

Neurological disorders caused by inherited ion-channel mutations

6

Neurological Disorders due to Recurrent Hypoglycemia

7

Neurological disturbances due to filgrastim

8

Neurological Dysfunction in Elderly Patients Undergoing Coronary Artery Bypass Operation

9

Neurological effects of high-dose idebenone in patients with Friedreichʹs ataxia: a randomised, placebo-controlled trial

10

Neurological efficacy of stavudine, zidovudine, and lamivudine

11

Neurological efficacy of stavudine, zidovudine, and lamivudine

12

Neurological evaluation and intelligence testing in the child with operated congenital heart disease

13

Neurological Examination and Hearing Assessment of Premature Infants with Gestational Age of Less Than 32 Weeks at Follow-up

14

Neurological examination findings to predict limitations in mobility and falls in older persons without a history of neurological disease

15

Neurological finding of Mitochondrial Syndromes (MERRF and MELAS)

16

Neurological findings and outcome in adult cerebral malaria

17

Neurological Functions of CEO Investment based on Varimax Analysis and Rotated Matrix in Q Typology

18

Neurological gait disorders in elderly people: clinical approach and classification

19

NEUROLOGICAL IMPROVEMENT AFTER CERVICAL TRACTION IN PATIENTS WITH CERVICAL SPINE INJURY

20

Neurological infection

21

Neurological infection in The Lancet Neurology

22

Neurological infections: clinical advances and emerging threats

23

Neurological infections: clinical advances, global threats

24

Neurological Involvement of Patients with COVID-19: Proposed Neuroinvasive Mechanisms and Management

25

Neurological manifestation of coeliac disease with particular emphasis on gluten ataxia and immunological injury: a review article

26

Neurological Manifestation of COVID-19: A Literature Review

27

Neurological Manifestations and Risk Factors of HTLV-1 Infection in the Middle East Region and Iran: A Comprehensive Review of 137 Articles of the Last 23 Years

28

Neurological Manifestations and their Correlated Factors in COVID-19 Patients; a Cross-Sectional Study

29

Neurological Manifestations as Presenting Feature of Osteopetrosis in Children; A Review of 11 Cases

30

Neurological Manifestations in Critically Ill COVID-19 Patients

31

Neurological manifestations in patients with antiphospholipid syndrome.

32

NEUROLOGICAL MANIFESTATIONS OF ALLGROVE SYNDROME

33

Neurological Manifestations of an Old Disease: A Case Report

34

Neurological manifestations of Behçet’s disease

35

Neurological Manifestations of Celiac Disease

36

Neurological manifestations of dengue infection Original Research Article

37

Neurological manifestations of Ehlers-Danlos syndrome(s): A review.

38

Neurological manifestations of Hansenʹs disease and their management

39

Neurological Manifestations of Hospitalized COVID-19-Infected Patients: A Single-Center Cohort Study

40

Neurological manifestations of knockout mice with β-galactosidase deficiency

41

Neurological Manifestations of Patients Hospitalized with Coronavirus Disease 2019 in Babol, Iran

42

Neurological Manifestations of Renal Diseases in Children in Qazvin/ Iran

43

NEUROLOGICAL MANIFESTATIONS OF WILSONʹS DISEASE

44

Neurological manifestations, diagnosis, and treatment of celiac disease: A comprehensive review

45

Neurological Measurement of Human Trust in Automation Using Electroencephalogram

46

Neurological mechanisms of green tea polyphenols in Alzheimerʹs and Parkinsonʹs diseases

47

Neurological melioidosis

48

Neurological Monitoring and Off-Pump Surgery in a Very High-Risk Stroke Patient

49

Neurological outcome and S100 after coronary artery bypass grafting and abdominal aortic surgery

50

Neurological outcome following delayed fixation of unstable thoracolumbar spinal injuries with short segment posterior fixation

51

Neurological outcome of normothermic versus hypothermic cardiopulmonary bypass in simple congenital heart diseases

52

Neurological outcomes in coronary surgery: independent effect of avoiding cardiopulmonary bypass

53

Neurological presentation of Griscelli syndrome: Obstructive hydrocephalus without haematological abnormalities or organomegaly

54

Neurological presentation of three patients with 22q11 deletion (CATCH 22 syndrome)

55

Neurological presentations of nutritional vitamin B12 deficiency in 42 breastfed infants in Southeast Turkey

56

Neurological prognosis correlated with variations over time in the number of subependymal nodules in tuberous sclerosis

57

Neurological recovery in 80 cases of rapid stereotactic evacuation and local fibrinolysis in spontaneous hematomas of putamen and thalamus

58

Neurological Rehabilitation of Stroke Patients by Means of a Robotically Assisted Brain Controlled Interface

59

Neurological sequelae following a high voltage electrical burn

60

Neurological sequelae in children born after in-vitro fertilisation: a population-based study

61

Neurological sequelae in in-vitro fertilisation babies

62

Neurological sequelae in in-vitro fertilisation babies

63

Neurological sequelae in in-vitro fertilisation babies

64

Neurological sequelae in in-vitro fertilisation babies

65

Neurological sequelae of cerebral malaria

66

Neurological sequelae of cerebral malaria

67

Neurological Sequels and Their Causes in Patients Hospitalized in the Toxicology Intensive Care Unit of Bahraloo Hospital, Tehran, Iran

68

Neurological soft signs and response to risperidone in chronic schizophrenia

69

Neurological soft signs in bipolar I disorder patients

70

Neurological soft signs in schizophrenia: Are they related to negative or positive symptoms, neuropsychological performance, and violence?

71

Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia

72

Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder

73

Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder?

74

Neurological Study of Radial Nerve Conduction During Endoscopic Radial Artery Harvesting:An Intra‐Operative Evaluation

75

Neurological Symptom in a Case of Adrenal Insufficiency

76

Neurological Symptoms as the First Presentation of Transitional Cell Carcinoma of Renal Pelvis

77

Neurological Wilson Disease in children: a three years experience from Multan

78

Neurologists are not immune

79

Neurologists determine the effect of migraine on quality of life

80

Neurologists give better stroke care

81

Neurologists say Florida woman is very unlikely to recover

82

83

Neurology elective at The Royal London Hospital

84

Neurology in sub-Saharan Africa—WHO cares?

85

Neurology of paediatric infectious diseases and immunodeficiency

86

Neurology of Touretteʹs syndrome (TS) TS as a developmental dopamine disorder: a hypothesis

87

Neurology of widely embedded free will

88

Neurology on the global health agenda

89

Neurology residency training in Europe: an Italian perspective

90

Neurology starters: simple to sublime

91

Neurology training around the world

92

Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis

93

Neurolymphomatosis in Recrudescent Diffuse Large B-cell Lymphoma

94

Neurolymphomatosis of brachial plexus: A rare clinical presentation and the role of 18F-FDG PET/CT

95

Neuromagnetic activity in alpha and beta bands reflect learning-induced increases in coordinative stability

96

Neuromagnetic alpha suppression during an auditory Sternberg task: Evidence for a serial, self-terminating search of short-term memory

97

Neuromagnetic correlates of intra- and extra-dimensional set-shifting

98

Neuromagnetic effects on Anomalous Cognitive Experiences: A Critical Appraisal of the Evidence for Induced Sensed-presence and Haunt-type Experiences

99

Neuromagnetic imaging of cortical oscillations accompanying tactile stimulation

100

Neuromagnetic responses to vowels vs. tones reveal hemispheric lateralization

101

Neuromagnetic source localization of auditory evoked fields and intracerebral evoked potentials: a comparison of data in the same patients

102

Neuromarketing: beyond branding

103

Neuromarketing: Where marketing and neuroscience meet

104

Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo

105

Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway

106

Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids

107

Neurometabolic Diagnosis in Children who referred as Neurodevelopmental Delay (A Practical Criteria, in Iranian Pediatric Patients)

108

Neurometabolic Registry Site in Iran

109

110

Neuro-models for discharge air temperature system

111

Neuromodulation of parietal and motor activity affects motor planning and execution

112

Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia

113

Neuromodulation: acetylcholine and memory consolidation

114

Neuromodulation: An Overview

115

Neuromodulations of the Intractable Neurologic Symptoms

116

Neuromodulatory control of hippocampal function: towards a model of Alzheimer’s disease

117

Neuromodulatory role of Bacopa monnieri on oxidative stress induced by postnatal exposure to decabromodiphenyl ether (PBDE -209) in neonate and young female mice

118

Neuromodulatory unpaired median neurons in the New Zealand tree weta, Hemideina femorata

119

Neuromolecularware and its application to pattern recognition

120

Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation

121

Neuromonitoring for awareness during surgery

122

Neuromonitoring of the external branch of the superior laryngeal nerve during thyroid surgery

123

Neuro-monte carlo solution of electrostatic problems

124

Neuromorbidity in preterm twins in relation to chorionicity and discordant birth weight

125

Neuromorphic implementation of orientation hypercolumns

126

Neuromorphic Synapses for Artificial Dendrites

127

Neuromotor control in stuttering: Speech, orofacial nonspeech, and finger movements

128

Neuromotor Issues in Human Performance: Introduction

129

Neuromotor Issues in the Learning and Control of Golf Skill

130

Neuro-mucormycosis: Lessons from COVID-19-associated cases

131

Neuromuscular Adjustments of the Quadriceps Muscle After Eccentric Resistance and Concentric Resistance Training

132

Neuromuscular and balance responses to flywheel inertial versus weight training in older persons

133

Neuromuscular and Blood Lactate Response After a Motocross Training Session in Amateur Riders

134

Neuromuscular and Metabolic Responses to Three Different Resistance Exercise Methods

135

Neuromuscular and psychomotor abnormalities in patients with schizophrenia and their first-degree relatives

136

Neuromuscular and spatial constraints on bimanual hand-held pendulum oscillations: Dissociation or combination?

137

Neuromuscular Blockade After Ingestion of Tree Tobacco (Nicotiana glauca), ,

138

Neuromuscular blockade as part of an anaesthetic protocol for cataract surgery in an alpaca

139

Neuromuscular Blockade, Bariatric Surgeon Satisfaction, and Quality of Patient Recovery

140

Neuromuscular Blocking Agent Use in Acute Respiratory Distress Syndrome: Which Variable is Important?

141

NEUROMUSCULAR BLOCKING AGENTS IN THE INTENSIVE CARE UNITS

142

Neuromuscular changes in a rat model of colitis

143

Neuromuscular Characteristics of Endurance- and Power-Trained Athletes

144

Neuromuscular consequences of prolonged hunger strike: an electrophysiological study

145

Neuromuscular Control and Coordination During Cycling

146

Neuromuscular control model of the arm including feedback and feedforward components

147

Neuromuscular disease laboratory

148

Neuromuscular diseases: therapeutic advances

149

Neuromuscular disorder in response to anterior cruciate ligament creep

150

Neuromuscular disorders in critical illness

151

Neuromuscular disorders: molecular and therapeutic insights

152

Neuromuscular disorders: orphan diseases deserve attention

153

Neuromuscular disorders: therapeutic advances

154

Neuromuscular dysfunction associated with delayed weaning from mechanical ventilation in patients with respiratory failure

155

NEUROMUSCULAR EFFECTS OF CISATRACURIUM IN MORBIDLY OBESE PATIENTS

156

Neuromuscular Electric Stimulation Versus Traditional Treatment on Harris Hip Score in Cases of Avascular Necrosis of Femoral Head After Kidney Transplantation

157

NEUROMUSCULAR ELECTRICAL STIMULATION OF MEDIUM an‎d LOW FREQUENCY ON THE QUADRICEPS FEMORIS

158

Neuromuscular Electrical Stimulation of the Cricothyroid Muscle in Patients With Suspected Superior Laryngeal Nerve Weakness

159

Neuromuscular excitability properties in myotonic dystrophy type 1

160

Neuromuscular function and bone density as independent predictors of fracture in older women: A 10-year longitudinal study

161

Neuromuscular implications in left ventricular hypertrabeculation/noncompaction

162

Neuromuscular mechanisms and anthropometric modifications in the initial stages of independent gait

163

Neuromuscular Mechanisms of Primary Peristalsis

164

Neuromuscular neutral zones response to cyclic lumbar flexion

165

Neuromuscular neutral zones response to static lumbar flexion: Muscular stability compensator

166

Neuromuscular neutral zones sensitivity to lumbar displacement rate

167

Neuromuscular objectives of the human masticatory apparatus during static biting

168

Neuromuscular Problems in the Patients With COVID-19: A Review Study

169

Neuromuscular recovery in ACL reconstruction with Bone-Tendon-Patellar-Bone and Semitendinosus-Gracilis autograft

170

Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial

171

Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy

172

Neuromuscular variables affecting the magnitude of force loss after eccentric exercise

173

Neuromuscular versus behavioural influences on reaching performance in young and elderly women

174

Neuromyelitis optica — Devicʹs syndrome, update

175

Neuromyelitis Optica and Nucleotide Variations of Aquaporin-4 Gene

176

Neuromyelitis optica in a patient with an early onset demyelinating episode: Clinical and autoantibody findings

177

Neuromyelitis optica in a pregnant woman with systemic lupus erythematous: A case report

178

Neuromyelitis Optica in Children: A Rare Entity

179

Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross‑sectional study

180

Neuromyelitis optica: what it is and what it might be

181

182

Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies)

183

Neuromythology of Einstein’s brain

184

Neuron Cell Type-specific SNAP-25 Expression Driven by Multiple Regulatory Elements in the Nematode Caenorhabditis elegans

185

Neuron death due to unfolded protein response in gangliosidosis

186

Neuron death in ALS may be due to effects of neighbours

187

Neuron firing in driven nonlinear integrate-and-fire models

188

Neuron loss after coronary artery bypass detected by SPECT estimation of benzodiazepine receptors

189

Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis Review Article

190

Neuron Mathematical Model Representation of Neural Tensor Network for RDF Knowledge Base Completion

191

Neuron Numbers and Volume of the Amygdala in Subjects Diagnosed with Bipolar Disorder or Schizophrenia

192

Neuron source energy on resonance absorption

193

Neuronal activation and plasticity in Schistosoma mansoni infected mice

194

Neuronal activation in response to isoproterenol (Iso) in 6-day-old rat pups

195

Neuronal activity in the basal ganglia and thalamus in patients with dystonia

196

Neuronal and glial cell types revealed by NADPH-diaphorase histochemistry in the retina of a teleost fish, the grass goby (Zosterisessor ophiocephaluSy Perciformes, Gobiidae)

197

Neuronal and glial changes in the brain resulting from explosive blast in an experimental model

198

Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain

199

Neuronal and microglial cathepsins in aging and age-related diseases

200

Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer

201

Neuronal Approach and the Use of KIK-NET Network to Generate Response Spectrum on the Surface

202

Neuronal assemblies: necessity, signature and detectability

203

Neuronal autoantibodies in focal epilepsy with or without mesial temporal sclerosis

204

Neuronal BC1 RNA: Microtubule-dependent Dendritic Delivery

205

Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease

206

Neuronal Cell Death in the Ischemic Spinal Cord: The Effect of Methylprednisolone

207

Neuronal cell death, nerve growth factor and neurotrophic models: 50 years on

208

Neuronal cell protective and antioxidant effects of phenolics obtained from Zanthoxylum piperitum leaf using in vitro model system

209

Neuronal Cell Reconstruction with Umbilical Cord Blood Cells in the Brain Hypoxia-Ischemia

210

Neuronal ceroid lipofuscinosis in a 31-year-old woman presenting as biventricular heart failure with restrictive features

211

Neuronal ceroid-lipofuscinosis: late infantile form or juvenile form?

212

Neuronal Changes in Normal Human Aging and Alzheimerʹs Disease

213

Neuronal circuitries involved in thermoregulation

214

Neuronal codes: reading them and learning how their structure influences network organization

215

Neuronal computers Original Research Article

216

Neuronal connections of the paratrigeminal nucleus: a topographic analysis of neurons projecting to bulbar, pontine and thalamic nuclei related to cardiovascular, respiratory and sensory functions

217

Neuronal contact guidance in magnetically aligned fibrin gels: effect of variation in gel mechano-structural properties

218

Neuronal Control of Metabolism through Nutrient-Dependent Modulation of Tracheal Branching

219

Neuronal correlates of “free will” are associated with regional specialization in the human intrinsic/default network

220

Neuronal Correlates of Colour-Graphemic Synaesthesia: Afmri Study

221

Neuronal correlates of context-related behavior

222

Neuronal Correlates of Obsessions in the Caudate Nucleus

223

Neuronal damage after hypothermic circulatory arrest and retrograde cerebral perfusion in the pig

224

Neuronal damage of the dorsal hippocampus induced by long-term right common carotid artery occlusion in rats

225

Neuronal death in the central nervous system during development

226

Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection

227

Neuronal differentiation modifies the effect of ethanol exposure on voltage-dependent calcium channels in NG 108-15 cells

228

Neuronal differentiation of induced pluripotent stem cells in hybrid polyester scaffolds with heparinized surface

229

Neuronal differentiation of mouse amnion membrane derived stem cells in response to neonatal brain medium

230

Neuronal Differentiation of Mouse Embryonic Stem Cells: Lineage Selection and Forced Differentiation Paradigms

231

Neuronal Differentiation of Rat Hair Follicle Stem Cells: the Involvement of the Neuroprotective Factor Seladin-1 (DHCR24)

232

Neuronal DNA damage correlates with overexpression of interleukin-1β converting enzyme in APPV717F mice

233

Neuronal effects of auditory distraction on visual attention

234

Neuronal Environment: the Brain Homeostasis in Health and Disease: W. Waltz, Humana Press, ISBN 0-89603-882-3, $145.00

235

Neuronal event detection in fMRI time series using iterative deconvolution techniques

236

Neuronal evolution: analysis of regulatory genes in a first-evolved nervous system, the hydra nervous system

237

Neuronal expression of Raf protooncogene in the brain stem of adult guinea pig

238

Neuronal feedback between brain and inner ear for growth of otoliths in fish Original Research Article

239

Neuronal firing activity in the dorsal hippocampus during the auditory discrimination oddball task in awake rats: relation to event-related potential generation

240

Neuronal function in chronic spinal cord injury: Divergence between locomotor and flexion- and H-reflex activity

241

Neuronal injury and death following focal mild brain injury: The role of network excitability and seizure

242

Neuronal Innervation, Intracellular Signal Transduction and Intercellular Coupling: a Model for Syncytial Tissue Responses in the Steady State

243

Neuronal Inputs from the Hypothalamus and Brain Stem to the Medial Preoptic Area of the Ram: Neurochemical Correlates and Comparison to the Ewe

244

Neuronal instability: implications for Rettʹs syndrome

245

Neuronal insulin signal transduction mechanisms in diabetes phenotypes

246

Neuronal intranuclear inclusion disease: neuropathologic study of a case

247

Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity

248

Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity

249

Neuronal lipofuscinosis

250

Neuronal loss and β-amyloid removal in the amygdala of people with Down syndromesmall star, filled

251

Neuronal loss in the colon of constipated Parkinsonʹs disease patients mimics that in the brain

252

Neuronal MAP2 mRNA: Species-dependent Differential Dendritic Targeting Competence

253

Neuronal maturation and N-acetyl-l-aspartic acid development in human fetal and child brains

254

Neuronal mechanisms mediating drug-induced cognition enhancement: cognitive activity as a necessary intervening variable

255

Neuronal Microtubule-associated Proteins: Insights into Their Structures and Functions

256

Neuronal migrational disorders in children with epilepsy: MRI, interictal SPECT and EEG comparisons

257

Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues

258

Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds

259

Neuronal nicotinic receptors and ligands

260

Neuronal nitric oxide synthase (NNOS) catalyzes one-electron reduction of 2,4,6-trinitrotoluene, resulting in decreased nitric oxide production and increased nNOS gene expression: implication for oxidative stress

261

Neuronal nitric oxide synthase activity is increased during granulomatous inflammation in the colon and caecum of pigs infected with Schistosoma japonicum

262

Neuronal Nitric Oxide Synthase Expression in the Anterior Vaginal Wall of Patients with Stress Urinary Incontinence

263

Neuronal nitric oxide synthase gene transfer decreases [Ca2+]i in cardiac sympathetic neurons

264

Neuronal Nitric Oxide Synthase is Refractory to Mechanism-Based Inactivation in GH3Pituitary Cells

265

Neuronal Nitric Oxide Synthase–Membrane Phospholipid Interactions

266

Neuronal NO synthase (NOS1) is a major candidate gene for asthma

267

Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in the early human fetal nervous system

268

Neuronal organization and cell interactions of the cat stellate ganglion

269

Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging

270

Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity

271

Neuronal Phenomena Associated with Vigilance and Consciousness: From Cellular Mechanisms to Electroencephalographic Patterns,

272

Neuronal plasticity and survival in mood disorders

273

Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes

274

Neuronal porosome – The secretory portal at the nerve terminal: Its structure–function, composition, and reconstitution

275

Neuronal projections from ventral tegmental area to forebrain structures in rat studied by manganese-enhanced magnetic resonance imaging

276

Neuronal representations of cognitive state: reward or attention?

277

Neuronal stem cells: a tale of promise and caution

278

Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntingtonʹs Disease Treatment Original Research Article

279

Neuronal subpopulations and genetic background in tauopathies: a catch 22 story?

280

Neuronal subserving of behavior before and after chronic ethanol treatment

281

Neuronal substrates of sensory gating within the human brain

282

Neuronal substrates participating in attentional set-shifting of rules for visually guided motor selection: a functional magnetic resonance imaging investigation

283

Neuronal Subtype Specification within a Lineage by Opposing Temporal Feed-Forward Loops

284

Neuronal susceptibility to damage: comparison of the retinas of young, old and old/caloric restricted rats before and after transient ischemia

285

Neuronal synchrony detection on single-electron neural networks

286

Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Downʹs syndrome: a gene expression study

287

Neuronal toxicity of biopolymer-template synthesized ZnO nanoparticles

288

Neuronal, mesenchymal and hematopoietic cell derived from CD34− lin− cell from adult bone marrow

289

Neuronally-expressed necdin gene: an imprinted candidate gene in Prader-Willi syndrome

290

Neuronavigated repetitive transcranial magnetic stimulation in patients with tinnitus: a short case series

291

Neuronavigation assisted endoscopic sinus surgery

292

Neuronavigation for Intraoperative Localization of Cerebral Aneurysms

293

Neuronavigation for transcranial magnetic stimulation (TMS): Where we are and where we are going

294

Neuron-based VLSI architecture for real-time camera distortion correction

295

Neuron-controlled robots

296

Neuron-MOS Parallel Search Hardware for Real-Time Signal Processing

297

Neuronorm is a potent and water soluble neurokinin A receptor antagonist

298

Neurons and neuronal systems involved in the pathophysiologies of Rett syndrome

299

Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimerʹs disease

300

Neurons don’t represent

301

Neurons in amygdala mediate ear pinna vasoconstriction elicited by unconditioned salient stimuli in conscious rabbits

302

Neurons lose inhibitions in epilepsy

303

Neurons regenerate in absence of reactive astrocytes

304

Neurons, Cooperativity and the Role of Noise in Brain

305

Neurons, glia, and plasticity in normal brain aging

306

Neurons, viscose fluids, freshwater polyp hydra-and self-organizing information systems

307

Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke

308

Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome

309

Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome

310

Neuron-Specific enolase as a marker for acute ischemic stroke: A systematic review

311

Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy

312

Neuron-specific enolase in cerebrospinal fluid as a neurochemical marker for brain damage in acute lymphoblastic leukemia

313

Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation

314

Neuron-specific enolase levels in the cerebrospinal fluid of neurologically healthy children

315

Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis

316

Neuron-specific susceptibility to apolipoprotein E4

317

Neuron-synapse IC chip-set for large-scale chaotic neural networks

318

Neuron-type polypyrrole device prepared by electrochemical polymerization method and its properties

319

Neuro-oncology for non-oncologists

320

Neuro-oncology for Nurses; Edited by Douglas Guerrero, Whur Publishers Ltd, £24.50

321

Neuro-oncology: diagnosis in the spotlight

322

Neuro-oncology: new insights and advances in treatment

323

Neuro-oncology: oligodendroglioma and molecular markers

324

Neuro-oncology: setting new standards of management

325

Neuro-oncology: the growing role of chemotherapy in glioma

326

Neuro-Ophthalmologic and Electroretinographic Finding in Pantothenate Kinae-Aociated Neurodegeneration (formerly Hallervorden-patz yndrome)

327

Neuro-Ophthalmologic Preentation of Hemicrania Continua

328

Neuro-ophthalmologic Recovery Following Endoscopic Endonasal Resection of Pituitary Macro-adenomas with Apoplexy

329

Neuro-ophthalmology review manual, revied 5th edition: Lanning B. Kline and Frank J. Bajanda. lack Incorporated: Thorofare, NJ; 2004.288 page$44.95 UDIBN 1-55642-672-0Media type: Review Manual

330

Neuro-Ophthalmology, The Requiite in Ophthalmology. Edited by Timothy J. Martin and Jame J. Corbett. t. Loui, Miouri, Moby Inc., 2000. Index, illutrated, 256 page. $89.00.

331

Neuro-ophthalmology: Neuronal Control of Eye Movements .A. Straube and U. Büttner Editors Basel Karger (2007).

332

Neuro-ophthalmology—Diagnoi and Management. Liu GT, Volpe NJ, Baletta L. New York, W.B. aunder, 2001. 756 page, index, illutrated. About $135.00

333

Neuro-optimal operation of a variable air volume HVAC&R system

334

Neuro-Optometry, Neuro-Optometrist, and Neuro-Optometric Rehabilitative Implications

335

Neuro-otologic Manifestations of Multiple Sclerosis

336

Neuro-otological features of Benign Paroxysmal Vertigo and Benign Paroxysmal Positioning Vertigo in children: A follow-up study

337

Neuropathic agents and pain. New strategies

338

Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases

339

Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases

340

Neuropathic diabetic patients do not have reduced variability of plantar loading during gait

341

Neuropathic elbow arthropathy: A review of six cases

342

Neuropathic gait shows only trends towards increased variability of sagittal plane kinematics during treadmill locomotion

343

Neuropathic injury to the levator ani occurs in 1 in 4 primiparous women

344

Neuropathic manifestations in rheumatoid arthritis : A clinical and electrophysiological assessment in a small sample of Iraqi patients.

345

Neuropathic Orofacial Pain: Proposed Mechanisms, Diagnosis, and Treatment Considerations

346

Neuropathic Osteoarthropathy in a Patient with Congenital Insensitivity to Pain

347

NEUROPATHIC PAIN

348

Neuropathic pain

349

Neuropathic pain

350

Neuropathic pain in hereditary coproporphyria

351

Neuropathic pain in soft tissue complaints

352

Neuropathic pain research pinpoints new role for microglia

353

Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail

354

Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail

355

Neuropathic Pain: A Review of Interneuronal Disinhibition

356

Neuropathic pain: aetiology, symptoms, mechanisms, and management

357

Neuropathic symptoms and findings in women with Fabry disease

358

Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature

359

Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature

360

Neuropathies of the foot

361

Neuropathogenicity of Equine Herpesvirus 9 in Cattle

362

Neuropathologic study of long term cyanide administration to goats

363

Neuropathological alteration of aquaporin 1 immunoreactive enteric neurons in the streptozotocin-induced diabetic rats

364

Neuropathological analysis of the brainstem and cerebral cortex lesions on epileptogenesis in hereditary dentatorubral-pallidoluysian atrophy

365

Neuropathological assessment of artemether-treated severe malaria

366

Neuropathological Changes in Brain Cortex and Hippocampus in a Rat Model of Alzheimer’s Disease

367

NEUROPATHOLOGICAL CHANGES IN THE PDAPP TRANSGENIC MOUSE MODEL OF ALZHEIMER S DISEASE

368

Neuropathological characteristics and alteration of the dopamine D2 receptor in hypoxic-ischemic basal ganglia necrosis

369

Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease

370

Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease: Are We Really Ready Yet?

371

Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies

372

Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms

373

Neuropathological findings in the cerebro-oculo-facio-skeletal (Pena-Shokeir II) syndrome

374

Neuropathological markers of impaired cognition in the entorhinal cortex

375

Neuropathological Staging of Alzheimer-Related Lesions: The Challenge of Establishing Relations to Age

376

Neuropathological studies of brain tissue in schizophrenia

377

Neuropathologies of the self: Clinical and anatomical features

378

Neuropathology and Genetics of Dementia, Edited by Tolnay M. and Probst A., Kluwer Academic/Plenum Publ., London, 2000.

379

Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging

380

Neuropathology of bipolar disorder

381

Neuropathology of chronic chagasic cardiopathy: A diagnostic reassessment

382

Neuropathology of developmental abnormalities

383

Neuropathology of early-infantile epileptic encephalopathy with suppression-bursts; comparison with those of early myoclonic encephalopathy and West syndrome

384

Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs

385

Neuropathology of prion diseases

386

Neuropathology of the limbic system and brainstem in West syndrome

387

Neuropathology of tuberous sclerosis

388

Neuropathology of variant Creutzfeldt-Jakob disease

389

Neuropathy complicating diffuse infiltrative lymphocytosis

390

Neuropathy in type 1 diabetic renal transplanted patients

391

Neuropathy of the suprascapular nerve and massive rotator cuff tears: a prospective electromyographic study

392

Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease

393

Neuropathy-induced osteopenia in rats is not due to a reduction in weight born on the affected limb

394

Neuro-PD Controller of Structural System to Mitigate Earthquake Vibrations

395

Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex

396

Neuropeptide deficits in schizophrenia vs. Alzheimerʹs disease cerebral cortex

397

Neuropeptide Delivery to Synapses by Long-Range Vesicle Circulation and Sporadic Capture

398

Neuropeptide enzyme hydrolysis in human saliva

399

Neuropeptide expression following ligation of the ferret lingual nerve

400

Neuropeptide expression in the ferret trigeminal ganglion following ligation of the inferior alveolar nerve

401

Neuropeptide FF attenuates RANKL-induced differentiation of RAW264.7 cells into osteoclast-like cells

402

Neuropeptide may shift rheumatoid arthritis into remission

403

Neuropeptide specificity of prostaglandin E2-induced activation of splenic and renal sympathetic nerves in the rat

404

Neuropeptide transmitters released from VAN into the NTS play an important role in regulating food intake

405

Neuropeptide Y (NPY) and NPY Y1 receptor in periodontal health and disease

406

Neuropeptide Y (NPY) revealed biological activity in leucocytes of Salmo salar

407

Neuropeptide Y (NPY): Genetic Variation in the Human Promoter Alters Glucocorticoid Signaling, Yielding Increased NPY Secretion and Stress Responses

408

Neuropeptide Y administered into cerebral ventricles stimulates sucrose ingestion in the near-term ovine fetus

409

Neuropeptide Y administration into the amygdala does not affect ethanol consumption

410

Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women

411

Neuropeptide Y expression, localization and cellular transducing effects in HUVEC

412

Neuropeptide Y Gene Promoter -399T/C Polymorphism Increases Risk of Ischemic Stroke

413

Neuropeptide Y immunohistochemistry and ultrastructure of developing chromaffin tissue in the cloudy dogfish, Scyliorhinus torazame (Chondrichthyes, Elasmobranchii)

414

Neuropeptide Y in male and female brains of flinders sensitive line, a rat model of depression. Effects of electroconvulsive stimuli

415

Neuropeptide Y in neural crest-derived tumors: Effect on growth and vascularization

416

Neuropeptide Y in the rostral ventrolateral medulla blocks somatosympathetic reflexes in anesthetized rats

417

Neuropeptide Y Inhibits in Vivo Specific Antibody Production in Rats

418

Neuropeptide Y modulation of sympathetic activity in myocardial infarction

419

Neuropeptide Y mRNA expression in interneurons in rat spinal cord

420

Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation

421

Neuropeptide Y receptors; antisecretory control of intestinal epithelial function

422

Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway

423

Neuropeptide Y restores appetite and alters concentrations of GH after central administration to endotoxic sheep

424

Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: The Helsinki Sudden Death Study

425

Neuropeptide Y suppresses ethanol drinking in ethanol-abstinent, but not non–ethanol-abstinent, Wistar rats

426

Neuropeptide Y Y1 receptor functional responsiveness is enhanced during cardiomyocyte hypertrophy

427

Neuropeptide Y, α-melanocyte–stimulating hormone, and monoamines in food intake regulation

428

Neuropeptide Y1 Receptor NPY1R: Discovery of Naturally Occurring Human Genetic Variants Governing Gene Expression In Cella as Well as Pleiotropic Effects on Autonomic Activity and Blood Pressure In Vivo

429

Neuropeptide Y1 receptor NPY1R: discovery of naturally occurring human genetic variants governing gene expression in cella as well as pleiotropic effects on autonomic activity and blood pressure in vivo.

430

Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat

431

NEUROPEPTIDES (SP an‎d CGRP) AUGMENT IL-1 BETA PRODUCTION IN HSV-INFECTED MACROPHAGES

432

Neuropeptides and endothelial injury in cutaneous vasculitis

433

Neuropeptides and obesity

434

Neuropeptides: opportunities for drug discovery

435

Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report

436

Neuropharmacological activity of the aqueous leaf extract of Croton zambesicus (euphorbiaceae) in some laboratory animals

437

Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson’s disease

438

Neuropharmacological Effect of the Rhizome of Drynaria quercifolia in Mice

439

Neuropharmacological Effects of Chassalia curviflora (Rubiaceae) Leaves in Swiss Albino Mice Model

440

Neuro-pharmacological effects of Crinum zeylanicum in mice

441

Neuropharmacological effects of methanolic extracts of Rubus fruticosus L.

442

Neuropharmacological effects of Nigella sativa

443

Neuropharmacological effects of Ocimum basilicum and its constituents

444

Neuropharmacological effects of standardized aqueous stem bark extract of Parkia biglobossa in Wistar rats

445

Neuropharmacological key to cortical plasticity found

446

Neuropharmacological properties of farnesol in Murine model

447

Neuropharmacological studies of ethanolic extract of Vaccinium corymbosum on Alzheimer’s type dementia and catatonia in Swiss albino mice

448

Neuropharmacological studies with spect in neuropsychiatric disorders

449

Neuropharmacology of depression in aging and age-related diseases

450

Neuropharmacology of endogenous, synthetic andphytocannabinoids for pain management

451

Neuropharmacology of timing and time perception

452

Neuropharmacology of timing and time perception: [Cognitive Brain Research 3 (1996) 227–242]

453

Neurophenomenology and the study of self-consciousness

454

Neurophil reactive chlorinating species target tissue plasmalogens: Production of 2-chlorohexadecal

455

Neurophysical theory of coherence and correlations of electroencephalographic and electrocorticographic signals

456

Neurophysiologic and intellectual evaluation of beta-thalassemia patients

457

Neurophysiologic assessment of mucopolysaccharidosis III

458

Neurophysiologic consequences of neonatal ethanol exposure in the rat

459

Neurophysiologic correlates of deficient phonological representations and object naming in prematurely born children

460

Neurophysiologic correlates of psychiatric disorders and potential applications in epilepsy

461

Neurophysiologic detector—a selective and sensitive tool in high-performance liquid chromatography

462

Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy

463

Neurophysiological and behavioral concomitants of mild brain injury in collegiate athletes

464

Neurophysiological and behavioral indices of time pressure effects on visuomotor task performance

465

Neurophysiological and behavioural evidence for an olfactory function for the dorsal organ and a gustatory one for the terminal organ in Drosophila melanogaster larvae

466

Neurophysiological and functional MRI evidence of reorganization of cortical motor areas in cerebral arteriovenous malformation

467

Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes

468

Neurophysiological assessment of the sedative and analgesic effects of a constant rate infusion of dexmedetomidine in the dog

469

Neurophysiological assessment of trigeminal nerve reflexes in disorders of central and peripheral nervous system

470

Neurophysiological bases underlying the organization of intentional actions and the understanding of others’ intention

471

Neurophysiological changes associated with psychiatric symptoms in HIV-infected individuals without AIDS

472

Neurophysiological Changes Associated with Selective Neuronal Damage in Hippocampus following Transient Forebrain Ischemia

473

Neurophysiological characteristics of photophobia in migraine

474

Neurophysiological correlate of clinical signs in Parkinsonʹs disease

475

Neurophysiological Correlates of Affiliative Behaviour between Humans and Dogs

476

Neurophysiological correlates of subjective significance

477

Neurophysiological correlates of the recognition of facial expressions of emotion as revealed by magnetoencephalography

478

Neurophysiological effects of recurrent laryngeal and thoracic vagus nerves on mediating the neurogenic inflammation of the trachea, bronchi, and esophagus of rats

479

Neurophysiological evaluation of symptomatically unaffected muscles in post polio syndrome (PPS)

480

Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine

481

Neurophysiological evidence for categorical perception of color

482

Neurophysiological evidence of cognitive inhibition anomalies in persons with major depressive disorder

483

Neurophysiological follow-up of motor cortical output in stroke patients

484

Neurophysiological index is a marker of functional impairment in amyotrophic lateral sclerosis

485

Neurophysiological indices of attention to speech in children with specific language impairment

486

Neurophysiological indices of strategy development and skill acquisition

487

Neurophysiological investigation of a chronic sensory ataxia

488

Neurophysiological marker of inhibition distinguishes language groups on a non-linguistic executive function test

489

Neurophysiological markers in familial amyloid polyneuropathy patients: Early changes

490

Neurophysiological markers of contextual processing: The relationship between P3b and Gamma synchrony and their modulation by arousal, performance and individual differences

491

Neurophysiological markers of early language acquisition: from syllables to sentences

492

Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 1. Recovery time of corticospinal tract direct waves elicited by pairs of transcranial electrical stimuli

493

Neurophysiological mechanisms underlying motor evoked potentials in anesthetized humans.: Part 2. Relationship between epidurally and muscle recorded MEPs in man

494

Neurophysiological Methods in Occupational and Environmental Health: Methodology and Recent Findings

495

Neurophysiological monitoring in vascular surgery

496

Neurophysiological Responses to Traumatic Reminders in the Acute Aftermath of Serious Motor Vehicle Collisions Using [15O]-H2O Positron Emission Tomography

497

Neurophysiological self-control: Modulation in all things

498

Neurophysiological signals of working memory in normal aging

499

Neurophysiological signs of cocaine dependence: Increased electroencephalogram beta during withdrawal

500

Neurophysiological study in Pelizaeus-Merzbacher disease

501

Neurophysiological study of corticomotor pathways in restless legs syndrome

502

Neurophysiological study of facial chorea in patients with Huntingtonʹs disease

503

Neurophysiological study of secondary synchronous occipito-frontopolar spikes in childhood

504

Neurophysiological study on possible protective and therapeutic effects of Sidr (Zizyphus spina-christi L.) leaf extract in male albino rats treated with pentylenetetrazol

505

Neurophysiological study on sensorimotor control mechanism in superior colliculus of echolocating bat

506

Neurophysiological techniques in patients who are secondarily non-responsive to Botulinum toxin

507

Neurophysiologist reprimanded by UK General Medical Council

508

Neurophysiology and neuroanatomy of reflexive and volitional saccades as revealed by lesion studies with neurological patients and transcranial magnetic stimulation (TMS)

509

Neurophysiology and neuroanatomy of reflexive and volitional saccades: Evidence from studies of humans

510

Neurophysiology and neuroanatomy of reflexive and voluntary saccades in non-human primates

511

Neurophysiology and neuroanatomy of smooth pursuit in humans

512

Neurophysiology and neuroanatomy of smooth pursuit: Lesion studies

513

Neurophysiology for Detection of High Risk for Psychosis

514

Neurophysiology in the intensive care unit: Size (of surals) matters

515

Neurophysiology of Parkinsonʹs disease: from basic research to clinical correlates

516

Neurophysiology of Rett syndrome

517

Neurophysiology of Social Conduct and Impact of Adverse Exposures

518

Neurophysiology of spasms

519

Neurophysiology of swallowing

520

Neurophysiology of the neurogenic lower urinary tract disorders

521

Neurophysiology of Touretteʹs syndrome: pathophysiological considerations

522

Neurophysiology of unimanual motor control and mirror movements

523

Neurophysiology reference tome

524

Neuro-PID tracking control of a discharge air temperature system

525

Neuropil Alteration of the Habenula Nucleus in the Experimental Model of Schizophrenia Induced by Ketamine

526

Neuropilin-1 Expreion by Endothelial Cell and Retinal Pigment Epithelial Cell in Choroidal Neovacular Membrane

527

Neuropilins and semaphorins — from angiogenesis to autoimmunity

528

Neuroplasticity and schizophrenia

529

Neuroplasticity as a function of second language learning: Anatomical changes in the human brain

530

Neuroplasticity changes during space flight Original Research Article

531

Neuroplasticity Changes of Rat Brain by Musical Stimuli during Fetal Period

532

Neuroplasticity of face primary motor cortex control of orofacial movements

533

Neuroplasticity of face sensorimotor cortex and implications for control of orofacial movements

534

Neuroplasticity: Evidence from aphasia

535

Neuropolitics gone mad

536

Neuroprophylaxis with aminophylline and magnesium sulfate?

537

Neuroprostheses for leg function after spinal-cord injury

538

Neuroprotection after cardiac arrest

539

Neuroprotection After Traumatic Brain Injury: Is There any Hope?

540

Neuroprotection against ischemic brain injury conferred by a novel nitrate ester

541

Neuroprotection and anxiety like behavior reduction of Allium hirtifolium and Astragalus hamosus in the AB-injected rat

542

NEURO-PROTECTION AND NEURO-THERAPY EFFECTS OF Acalypha indica Linn. WATER EXTRACT EX VIVO ON Musculus gastrocnemius Frog

543

Neuroprotection and pharmacotherapy for motor symptoms in Parkinsonʹs disease

544

Neuroprotection and the role of neuroglobin

545

Neuroprotection by KATP channels

546

Neuroprotection by the Metabolic Antioxidant α-Lipoic Acid

547

Neuroprotection disappointment yet aGAIN

548

Neuroprotection Effect of Quercetin on TNF- Levels and Gene Expression of Caspase 3 in MPTP-Induced Male NMRI Mice

549

Neuroprotection failure in stroke

550

Neuroprotection for acute ischaemic stroke: hope reignited

551

Neuroprotection for Parkinsonʹs disease: a call for clinically riven experimental design

552

Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?

553

Neuroprotection in Cardiac Surgery

554

Neuroprotection in epilepsy: The Holy Grail of antiepileptogenic therapy

555

Neuroprotection in Glaucoma

556

Neuroprotection in Glaucoma

557

Neuroprotection in multiple sclerosis

558

Neuroprotection in Parkinsonʹs Disease

559

Neuroprotection in Parkinsonʹs disease: and now for something completely different?

560

Neuroprotection of a sesamin derivative, 1, 2-bis [(3-methoxy- phenyl) methyl] ethane-1, 2-dicaroxylic acid (MMEDA) against ischemic and hypoxic neuronal injury

561

Neuroprotective (+) 3S, 4S cannabinoids with modified 5′-side chain

562

Neuroprotective activities of acai berries (Euterpe sp.): A review

563

Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium–binding proteins

564

Neuroprotective adaptations in hibernation: therapeutic implications for ischemia-reperfusion, traumatic brain injury and neurodegenerative diseases

565

Neuroprotective Agents for Management of Parkinson’s disease

566

Neuroprotective agents: Cannabinoids

567

Neuroprotective and Antiamnesic Effects of Mitragyna inermis Willd (Rubiaceae) on Scopolamine-Induced Memory Impairment in Mice

568

Neuroprotective and anti-inflammatory effects of flavonoids isolated from Rhus verniciflua in neuronal HT22 and microglial BV2 cell lines

569

Neuroprotective and Anti-inflammatory Role of Atorvastatin and Its Interaction with Nitric Oxide (NO) in Chronic Constriction Injury-induced Neuropathic Pain

570

Neuroprotective and anti-neuroinflammatory activity of frankincense in bile duct ligation-induced hepatic encephalopathy

571

Neuroprotective and memory enhancing effects of Zataria multiflora in lipopolysaccharide-treated rats

572

Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior

573

Neuroprotective and Nootropic Activity of Carica Papaya Seeds on Diabetes induced Cognitive Decline in Rats

574

Neuroprotective and Nootropic Drug Noopept Rescues α-Synuclein Amyloid Cytotoxicity

575

Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury

576

Neuroprotective biflavonoids of Chamaecyparis obtusa leaves against glutamate-induced oxidative stress in HT22 hippocampal cells

577

Neuroprotective Consequences of Postconditioning on Embolic Model of Cerebral Ischemia in Rat

578

Neuroprotective Effect of Matricaria chamomilla Extract on Motor Dysfunction Induced by Transient Global Cerebral Ischemia and Reperfusion in Rat

579

Neuroprotective Effect of 4T1 and Sertoli Cells CoTransplantation in Animal Model of Brain Ischemia

580

Neuroprotective effect of Acorus calamus Linn. extract on a rat model of chronic constriction injury of median nerve-induced peripheral neuropathy

581

Neuroprotective effect of ACTH (4-9) in degeneration of hippocampal nerve cells caused by dexamethasone: morphological, immunocytochemical and ultrastructural studies

582

Neuroprotective effect of agmatine in rats with transient cerebral ischemia using MR imaging and histopathologic evaluation

583

Neuroprotective effect of alkyl hydroxytyrosyl ethers in rat brain slices subjected to a hypoxia-reoxygenation model

584

Neuroprotective effect of berberine chloride on cognitive impairment and hippocampal damage in experimental model of vascular dementia

585

Neuroprotective effect of blackberry (Rubus sp.) polyphenols is potentiated after simulated gastrointestinal digestion

586

Neuroprotective Effect of Celastrus Paniculatus Seed Extract on Epilepsy and Epilepsy-associated Cognitive Deficits

587

Neuroprotective Effect of Coenzyme Q10 in Chronic Constriction Injury-Induced Neuropathic Pain in Rat

588

Neuroprotective effect of Coenzyme Q10 in hippocampal injury in Balb/c mouse

589

Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein

590

Neuroprotective Effect of DAHP via Antiapoptosis in Cerebral Ischemia

591

Neuroprotective effect of Decalepis hamiltonii roots against ethanol-induced oxidative stress

592

Neuroprotective effect of dimethyl fumarate in stroke: The role of nuclear factor erythroid 2-related factor 2

593

Neuroprotective Effect of Erythropoietin in Postoperation Cervical Spinal Cord Injury: Case Report and Review

594

Neuroprotective effect of ethanolic leaf extract of Commiphora caudata (Wight Arn) against lipopolysaccharide-induced neurotoxicity in Wistar rats

595

Neuroprotective Effect of Exogenous Melatonin on Dopaminergic Neurons of the Substantia Nigra in Ovariectomized Rats

596

Neuroprotective effect of geraniol and curcumin in an acrylamide model of neurotoxicity in Drosophila melanogaster: Relevance to neuropathy

597

Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats

598

Neuroprotective effect of hexasulfobutylated C60 on rats subjected to focal cerebral ischemia

599

Neuroprotective effect of Launaea taraxacifolia against neuroinflammation, memory loss and neurobehavioral deficit in a rat model of hypertension: biochemical and immunohistochemical approaches

600

Neuroprotective effect of L-deprenyl on the expression level of the Mst1 gene and inhibition of apoptosis in rat-model spinal cord injury

601

Neuroprotective effect of melatonin in a rat model ofstreptozotocin-induced diabetic neuropathy: Light andelectron microscopic study

602

Neuroprotective Effect of Melatonin in the Hippocampus of Rat’s Brain in Normal Aging Model

603

Neuroprotective Effect of Melatonin on Brain Damage Induced by Acute Global Cerebral Ischemia in Cats

604

Neuroprotective effect of memantine on serum S100-B levels after on-pump coronary artery bypass graft surgery: A randomized clinical trial

605

Neuroprotective effect of methanolic extract of Sargassum wightii on rotenone-induced parkinsonism-like symptoms in Wistar albino rats

606

Neuroprotective Effect of Paroxetine on Memory Deficit Induced by Cerebral Ischemia after Transient Bilateral Occlusion of Common Carotid Arteries in Rat

607

Neuroprotective effect of p-coumaric acid in rat model of embolic cerebral ischemia

608

Neuroprotective Effect of Pentoxifylline on 3,4-Methylenedioxymethamphetamine-Induced Apoptosis in CA1 Cells of Wistar Rat Hippocampus

609

Neuroprotective Effect of Quercetin Encapsulated Liposomes: A Novel Therapeutic Strategy against Alzheimerʹs Disease

610

Neuroprotective Effect of Quercetin in a Model of Parkinson’s Disease in Rat: A histochemical Analysis

611

Neuroprotective effect of selective antegrade cerebral perfusion during prolonged deep hypothermic circulatory arrest: Cerebral metabolism evidence in a pig model

612

Neuroprotective effect of thymoquinone in acrylamide-induced neurotoxicity in Wistar rats

613

Neuroprotective Effect of Thymoquinone, the Nigella Sativa Bioactive Compound, in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Rat Model

614

Neuroprotective Effect of Total and Sequential Extract of Scrophularia striata Boiss. in Rat Cerebellar Granule Neurons Following Glutamate- Induced Neurotoxicity: An In-vitro Study

615

NEUROPROTECTIVE EFFECT OF VITAMIN C AGAINST PTZ INDUCED APOPTOTIC NEURODEGENERATION IN ADULT RAT BRAIN

616

Neuroprotective effect of water lily (Nymphaea pubescens Willd) seed ethanolic extract against trimethyltin-induced cognitive impairment and neurodegeneration in mice

617

Neuroprotective Effect of Zataria Multiflora Essential Oil on Rats With Alzheimer Disease: A Mechanistic Study

618

Neuroprotective Effects of 1,8-Cineole on Apoptosis Inhibition and Bcl-2/Caspase-3 mRNA Expression in the Hippocampus of Epileptic Pilocarpine Model Rats

619

Neuroprotective Effects of Acetyl-l-Carnitine After Stroke in Rats, , ,

620

Neuroprotective effects of alpha-lipoic acid on radiation-induced brainstem injury in rats

621

Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats

622

Neuroprotective Effects of Berberine Hydrochloride on Methamphetamine-induced Cognitive Dysfunction: Immunohistochemical and Behavioral Studies in Rats

623

Neuroprotective Effects of Bone Marrow Mesenchymal Stem Cells on Bilateral Common Carotid Arteries Occlusion Model of Cerebral Ischemia in Rat

624

Neuroprotective effects of caffeine against beta-amyliod neurotoxicity: The involvement of glycogen synthase kinase-3β protein

625

Neuroprotective Effects of Carnosic Acid in an Experimental Model of Alzheimer’s disease in Rats

626

Neuroprotective effects of carvacrol against Alzheimer’s disease and other neurodegenerative diseases: A review

627

Neuroprotective effects of celastrol on sciatic nerve transection model in male Wistar rats

628

Neuroprotective Effects of Chrysin Mediated by Estrogenic Receptors Following Cerebral Ischemia and Reperfusion in Male Rats

629

Neuroprotective effects of cognitive enrichment

630

Neuroprotective Effects of Combined Treatment with Minocycline and Olfactory Ensheathing Cells Transplantation against Inflammation and Oxidative Stress after Spinal Cord Injury

631

Neuroprotective effects of Coriandrum sativum and its constituent, linalool: A review

632

Neuroprotective effects of crocin on the histopathological alterations following brain ischemia-reperfusion injury in rat

633

Neuroprotective effects of curculigoside against NMDA-induced neuronal excitoxicity in vitro

634

Neuroprotective Effects of Curcumin Against Transient Global Ischemia are Dose and Area Dependent

635

Neuroprotective Effects of Curcumin on the Proliferation and Viability of Neural Stem Cells against H2O2

636

Neuroprotective effects of cystamine in aged parkinsonian mice

637

Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinsonʹs Disease

638

Neuroprotective Effects of Epigallocatechin-3-Gallate in an Experimental Model of Alzheimer’s Disease in Rat: A Histological Study

639

Neuroprotective effects of Equisetum telmateia in rat

640

Neuroprotective effects of Eriobotrya japonica against β-amyloid-induced oxidative stress and memory impairment

641

Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke

642

Neuroprotective Effects of Exercise on Brain Edema and Neurological Movement Disorders Following the Cerebral Ischemia and Reperfusion in Rats

643

Neuroprotective Effects of Fe3O4 Nanoparticles Coated with Omega-3 as a Novel Drug for Recovery of Sciatic Nerve Injury in Rats

644

Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells

645

Neuroprotective effects of gallic acid in a rat model of traumatic brain injury: behavioral, electrophysiological, and molecular studies

646

Neuroprotective Effects of Herbal Extract (Rosa canina, Tanacetum vulgare and Urtica dioica) on Rat Model of Sporadic Alzheimer’s Disease

647

Neuroprotective effects of intense training and thyme honey on hippocampal cognitive pathways in diabetic rats

648

Neuroprotective Effects of Isoquercetin: An In Vitro and In Vivo Study

649

Neuroprotective effects of kobophenol A against the withdrawal of tropic support, nitrosative stress, and mitochondrial damage in SH-SY5Y neuroblastoma cells

650

Neuroprotective Effects of Medicinal Plants and Their Constituents on Different Induced Neurotoxicity Methods: A Review

651

Neuroprotective Effects of Memantine in the Retina of Glaucomatous Rats: An Electron Microscopic Study

652

Neuroprotective effects of naturally occurring biflavonoids

653

Neuroprotective effects of neolignans isolated from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells

654

Neuroprotective Effects of Normobaric Hyperoxia and Transplantation of Encapsulated Choroid Plexus Epithelial Cells on The Focal Brain Ischemia

655

Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats

656

Neuroprotective effects of Pinus eldarica in a mouse model of pentylenetetrazole-induced seizures

657

Neuroprotective Effects of Pramipexole in Parkinson s Disease Induced by Rotenone in Mice

658

Neuroprotective Effects of Progesterone on Damage Elicited by Acute Global Cerebral Ischemia in Neurons of the Caudate Nucleus

659

Neuroprotective effects of propolis and caffeic acid phenethyl ester (CAPE) on the radiation-injured brain tissue (Neuroprotective effects of propolis and CAPE)

660

Neuroprotective effects of resveratrol on embryonic dorsal root ganglion neurons with neurotoxicity induced by ethanol

661

Neuroprotective effects of rosemary extract on white matter of prefrontal cortex in old rats

662

Neuroprotective effects of Salvia aristata Aucher ex Benth. on hydrogen peroxide induced apoptosis in SH-SY5Y neuroblastoma cells

663

Neuroprotective effects of Schisandrin B against transient focal cerebral ischemia in Sprague–Dawley rats

664

Neuroprotective effects of selenium and ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain

665

Neuroprotective Effects of Semaglutide in Endotoxemia Mouse Model

666

Neuroprotective effects of silymarin on sodium fluoride-induced oxidative stress

667

Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering

668

Neuroprotective effects of Tacca chantrieri Andre against lipopolysaccharide-induced cognitive impairment and neuroinflammation

669

Neuroprotective effects of Tiliacora triandra leaf extract in a mice model of cerebral ischemia reperfusion

670

Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE

671

Neuroprotective Effects of Vitamin D on Patients With Traumatic Brain Injury: A Clinical Trial

672

Neuroprotective Effects of Vitexin and Cajanus cajan Extract Against Pb-induced Neurotoxicity in Wistar Rats

673

Neuroprotective effects of voluntary wheel running and eriobotrya japonica flower extract on Parkinsonian rats

674

Neuroprotective effects of walnut (Juglans regia L.) in nervous system disorders: A comprehensive review

675

Neuroprotective effects of Wharton’s jelly-derived mesenchymal stem cells on motor deficits due to Parkinson’s disease

676

Neuroprotective effects of Withania coagulans root extract on CA1 hippocampus following cerebral ischemia in rats

677

Neuroprotective effects of xanthone derivative of Garcinia mangostana against lead-induced acetylcholinesterase dysfunction and cognitive impairment

678

Neuroprotective effects of Z-ajoene, an organosulfur compound derived from oil-macerated garlic, in the gerbil hippocampal CA1 region after transient forebrain ischemia

679

Neuroprotective effects of α-lipoic acid and its positively charged amide analogue

680

Neuroprotective gene profile in the brain of magnesium-deficient mice

681

Neuroprotective mechanism of bromocriptine

682

Neuroprotective or neurotoxic activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline and related compounds

683

Neuroprotective Plants; What, How, an‎d Why? A Narrative Review

684

Neuroprotective potential of some terebinth coffee brands and the unprocessed fruits of Pistacia terebinthus L. and their fatty and essential oil analyses

685

Neuroprotective Potential of Trans-Anethole Following Crush Injury of the Sciatic Nerve in Rats

686

Neuroprotective Properties of Melissa Officinalis L. Extract Against Ecstasy-Induced Neurotoxicity

687

Neuroprotective properties of Melissa officinalisafter hypoxic-ischemic injury both in vitro and in vivo

688

Neuroprotective Properties of Photobiomodulation in Retinal Regeneration in Rats: Perspectives From Interaction Levels

689

Neuroprotective properties of Spanish red wine and its isolated polyphenols on astrocytes

690

Neuroprotective role of curcumin on the hippocampus against the structural and serological alterations of streptozotocin-induced diabetes in Sprague Dawely rats

691

Neuroprotective role of vitamin D3 in colchicine-induced Alzheimer’s disease in rats

692

Neuroprotective roles of flavonoid “hispidulin” in the central nervous system: A review

693

Neuroprotective Strategies in the Perioperative Period: A Systematic Review

694

Neuroprotective therapy for acute ischaemic stroke: down, but not out

695

Neuroprotective Treatment With FK506 Reduces Hippocampal Damage and Prevents Learning and Memory Deficits After Transient Global Ischemia in Rat

696

Neuroprotective, antimicrobial, antioxidant, chemotherapeutic, and antidiabetic properties of Salvia Reuterana: A mini review

697

Neuroproteomics comes of age

698

Neuropsychiaric perspective and recommendations

699

Neuropsychiatric and neuropsychological manifestations of central pontine myelinolysis

700

Neuropsychiatric and Psychosocial Issues of Patients With Hepatitis C Infection: A Selective Literature Review

701

Neuropsychiatric aspects in Munchausenʹs syndrome

702

Neuropsychiatric aspects of epilepsy in children

703

Neuropsychiatric aspects of patients with hypothalamic hamartomas

704

Neuropsychiatric changes after liver transplantation

705

Neuropsychiatric Complications Following Liver Transplantation

706

NEUROPSYCHIATRIC COMPLICATIONS IN LIVER TRANSPLANT PATIENTS IN A TERTIARY HOSPITAL IN SINGAPORE

707

Neuropsychiatric Complications of COVID-19: What is to be Expected

708

Neuropsychiatric effects of medications for allergic diseases

709

Neuropsychiatric features of systemic lupus erythematosus

710

Neuropsychiatric Function and Dehydroepiandrosterone Sulfate in Elderly Women: A Prospective Study

711

Neuropsychiatric Illness: A Case for Impaired Neuroplasticity and Possible Quantum Processing Derailment in Microtubules

712

Neuropsychiatric implications of basal ganglia dysfunction

713

Neuropsychiatric Lupus

714

Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests,

715

Neuropsychiatric Manifestations in a Patientwith Panhypopituitarism

716

Neuropsychiatric Manifestations of COVID-19 in Hospitalized Pediatrics: A Multicenter Cross-sectional Study

717

Neuropsychiatric Manifestations of Partial Agenesis ofthe Corpus Callosum: A Case Report and Literature Review

718

Neuropsychiatric perspectives on nodding syndrome in northern Uganda: a case series study and a review of the literature

719

Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate

720

Neuropsychiatric reaction induced by abacavir

721

Neuropsychiatric reactions with mefloquine chemoprophylaxis

722

Neuropsychiatric sequelae in a case of St. Louis Encephalitis

723

Neuropsychiatric Symptoms As The First Manifestation of Juvenile Systemic Lupus Erythematosus: A Complicated Case With Klinefelterʹʹs Syndrome

724

Neuropsychiatric Syndromes and Occupational Exposure to Zinc Phosphide in Egypt

725

Neuropsychiatric systemic lupus erythematosus: Correlation of brain MR imaging, CT, and SPECT

726

Neuropsychiatric toxicity of Ifosfamide in patients admitted for chemotherapy

727

Neuropsychiatry and Behavioral Neuroscience

728

Neuropsychiatry in old age : by C. Stefanis and H. Hippius, 1996, Hogrefe & Huber Publishers, Seattle, USA, 171 pages, US$ 32, ISBN 0-88937-137-7

729

Neuropsychiatry, second edition.R.B. Schiffer, S.M. Roa and B.S. Fogel, Editors, Lippincott Williams & Wilkins, Philadelphia (2003) $169, 1312 pages.

730

Neuropsychiatry—a discipline for the future

731

Neuropsychiatryʹs offspring

732

Neuropsychiatry—The mind embrained?

733

Neuro-Psychoanalysis May Enliven the Mindbrain Sciences

734

Neuropsychologic and Functional Recovery From Severe Carbon Monoxide Poisoning Without Hyperbaric Oxygen Therapy, , ,

735

Neuropsychologic Changes After Coronary Artery Bypass Grafting: Use of Reliable Change Indices

736

Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading

737

Neuropsychologic Impairment in Patients with Nonepileptic Seizures

738

Neuropsychologic impairments in bipolar and unipolar mood disorders on the CANTAB neurocognitive battery

739

Neuropsychologic Theory and Findings in Attention-Deficit/Hyperactivity Disorder: The State of the Field and Salient Challenges for the Coming Decade

740

Neuropsychological abnormalities in cirrhosis include learning impairment

741

Neuropsychological and anatomical correlates of E4 in Alzheimerʹs disease

742

Neuropsychological and behavioral disorders as presentation symptoms in two brothers with early-infantile Niemann-Pick type C

743

Neuropsychological and cognitive psychophysiological substrates of impulsive aggression

744

Neuropsychological and Diagnostic Differences Between Recidivistically Violent Not Criminally Responsible and Mentally Ill Prisoners

745

Neuropsychological and emotional changes during simulated microgravity: effects of triiodothyronine, alendronate, and testosterone

746

Neuropsychological and Emotional Functioning in Patients with Cushing's Syndrome

747

Neuropsychological and mood effects of ketamine in electroconvulsive therapy: A randomised controlled trial

748

Neuropsychological and neurological correlates in an elderly rural population

749

Neuropsychological and neurophysiological deficits in extremely high velocity traumatic brain injury: A case report

750

Neuropsychological and Neuropsychiatric Deficits Following Traumatic Brain Injury: Common Patterns and Neuropathological Mechanisms

751

Neuropsychological and psychiatric changes after deep brain stimulation for Parkinsonʹs disease: a randomised, multicentre study

752

Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: A comparative short-term study

753

Neuropsychological and QEEG assessment of adult ADHD

754

Neuropsychological aspects of chronic relapsing pancreatitis: A longitudinal case study

755

Neuropsychological aspects of epilepsy surgery

756

Neuropsychological aspects of Tourette syndrome: A review

757

Neuropsychological aspects of type of epilepsy and etiological factors in adults

758

Neuropsychological assessment and volumetric magnetic resonance imaging of the corpus callosum in dementia

759

Neuropsychological Assessment In Epilepsy Surgery – Preliminary Experience In A Rural Tertiary Care Hospital In North East Malaysia

760

Neuropsychological assessment in patients evaluated for hyperthermia for metastatic nonsmall lung carcinoma (FDA phase 1 and phase 2)

761

Neuropsychological assessment of a rare systemic vascular disorder: a case study of Rendu—Osler—Weber syndrome

762

Neuropsychological Assessment of Organic Solvent Effects in South Africa: Test Selection, Adaptation, Scoring, and Validation Issues

763

Neuropsychological assessment of persons with physical disability, visual impairment or blindness, and hearing impairment or deafness

764

Neuropsychological assessment of relatively intact individuals: Psychometric lessons from an HIV+ sample

765

Neuropsychological assessment of the blind and visually impaired

766

Neuropsychological assessments before and aftertreatment in patients with anorexia nervosa and bulimianervosa

767

Neuropsychological change following gamma knife surgery in patients with left temporal lobe epilepsy: a review of three cases

768

Neuropsychological changes and treatment compliance in older adults with sleep apnea

769

Neuropsychological Changes in Complex Regional Pain Syndrome (CRPS)

770

Neuropsychological characterization of hepatic encephalopathy

771

Neuropsychological complaint base rates in personal injury, revisited

772

Neuropsychological consequences of bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinsonʹs disease: A 1-year longitudinal follow-up

773

Neuropsychological consequences of HIV in children: A review of current literature

774

Neuropsychological consequences of right thalamic haemorrhage: Case study and review

775

Neuropsychological consequences of sequential concussions in a female college basketball player

776

Neuropsychological correlates between working memory and executive functioning

777

Neuropsychological correlates of adjunct therapy with a nutritional/vitamin supplement in a medical patient sample

778

Neuropsychological Correlates of Community Function among Major Depressive Disorder Outpatients without Comorbidity in Hong Kong: An Exploratory Cross‑Sectional Study

779

Neuropsychological correlates of dominance, warmth, and extraversion in neurodegenerative disease

780

Neuropsychological correlates of Gulf War syndrome

781

Neuropsychological correlates of homocysteine levels in euthymic bipolar patients

782

Neuropsychological Correlates of Methylphenidate Treatment in Adult ADHD With and Without Depression

783

Neuropsychological correlates of opioid dependence and withdrawal

784

Neuropsychological correlates of psychopathic traits in a non-incarcerated sample

785

Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis

786

Neuropsychological correlates of self-reported impulsive aggression in a college sample

787

Neuropsychological correlates of violence and aggression: A review of the clinical literature

788

Neuropsychological decline following herpes zoster without encephalitis: A case study

789

Neuropsychological Decomposing Stroop Interference Into Different Cognitive Monitoring: An Exploratory Factor Analysis

790

Neuropsychological deficit profiles in senile dementia of the Alzheimerʹs type

791

Neuropsychological deficits among patients with late-onset minor and major depression

792

Neuropsychological deficits associated with chronic hepatitis C among male veterans

793

Neuropsychological deficits in bipolar depression persist after successful antidepressant treatment

794

Neuropsychological deficits in marijuana smokers

795

Neuropsychological deficits in probands from multiply-affected schizophrenic families

796

Neuropsychological deficits of patients with chronic or acute cerebellar lesions

797

Neuropsychological developmental change in a case with Noonan syndrome: longitudinal assessment

798

Neuropsychological Disorders in Patients with Brain Tumor

799

Neuropsychological dissociations between motion and form perception suggest functional organization in extrastriate cortical regions in the human brain

800

Neuropsychological double dissociation between linguistic levels: Clinical linguistic evidence from Iranian aphasic patients

801

Neuropsychological dysfunction after minimally invasive direct coronary artery bypass grafting

802

Neuropsychological Dysfunction in Children with Borderline Personality Disorder Features: A Preliminary Investigation

803

Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease

804

Neuropsychological dysfunction in patients with end-stage pulmonary disease: lung transplant evaluation

805

Neuropsychological dysfunction in patients with end-stage pulmonary disease: Lung transplant evaluation

806

Neuropsychological dysfunction in schizotypal personality disorder: A profile analysis

807

Neuropsychological Effects of Chronic Exposure to Environmental Dioxins and Furans

808

Neuropsychological effects of epilepsy and antiepileptic drugs

809

Neuropsychological effects of exposure to sheep dip

810

Neuropsychological effects of long-term exposure to organophosphates in sheep dip

811

Neuropsychological effects of seizures

812

Neuropsychological effects of stress on social phobia with and without comorbid depression

813

Neuropsychological evaluation in rehabilitation planning and evaluation of functional skills

814

Neuropsychological evaluation in the diagnosis and management of sports-related concussion

815

Neuropsychological Evaluation of Older Children : By Ralph M. Reitan and Deborah Wolfson, South Tucson, AZ: Neuropsychology Press, 1992. + 814 pp

816

Neuropsychological evidence for dimensional schizotypy: Implications for creativity and psychopathology

817

Neuropsychological exploration of alleged mold neurotoxicity

818

Neuropsychological explorations of memory and cognition: Essay in honor of Nelson butters :Eidted by Laird S. Cermak, N ew York: Plenum Press, 1994.

819

Neuropsychological features of diffuse Lewy body disease

820

Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation

821

Neuropsychological findings in adult attention deficit disorder

822

Neuropsychological findings in young-adult stroke patients

823

Neuropsychological follow-up of high risk infants at school age: Wechsler Verbal-Performance discrepancies

824

Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimers disease

825

Neuropsychological function and psychosocial status of alcohol rehabilitation program residents

826

Neuropsychological function in adults with attention-deficit hyperactivity disorder

827

Neuropsychological function in female victims of intimate partner violence with and without posttraumatic stress disorder

828

Neuropsychological function in unmedicated recurrent brief depression

829

Neuropsychological functioning following bilateral subthalamic nucleus stimulation in Parkinson’s disease

830

Neuropsychological functioning in a subclinical obsessive-compulsive sample

831

Neuropsychological Functioning in Adolescent Children of Mothers with a History of Bipolar or Major Depressive Disorders

832

Neuropsychological functioning in adult insulin-dependent diabetes mellitus (IDDM) patients

833

Neuropsychological Functioning in Bipolar Disorder and Schizophrenia

834

Neuropsychological functioning in chronic lyme disease: The role of mental effort

835

Neuropsychological Functioning in Danish Gulf War Veterans

836

Neuropsychological functioning in depressed adolescent girls

837

Neuropsychological functioning in kleptomania

838

Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants

839

Neuropsychological Functioning in Migraine Headache, Nonheadache Chronic Pain, and Mild Traumatic Brain Injury Patients

840

Neuropsychological Functioning in Obsessive-Compulsive Washers: Drug-Naive Without Depressive Symptoms

841

Neuropsychological functioning in people with ADHD across the lifespan

842

Neuropsychological functioning in sons of active alcoholic, recovering alcoholic, and social drinking fathers

843

Neuropsychological functioning in trichotillomania

844

Neuropsychological functioning in two brothers with X-linked adrenoleukodystrophy: A longitudinal case study of phenotypic variation and bone marrow transplant outcome

845

Neuropsychological Functioning in Youth with Bipolar Disorder

846

Neuropsychological functioning of children and adolescents with conduct disorder and aggressive-assaultive features

847

Neuropsychological functioning of dementia patients with psychosis

848

Neuropsychological Functioning of Inmates Referred for Psychiatric Treatment

849

Neuropsychological Functioning: Comparison of Mothers at High- and Low-Risk for Child Physical Abuse

850

Neuropsychological functions and the BASC

851

Neuropsychological functions in anxiety disorders in population-based samples: evidence of episodic memory dysfunction

852

Neuropsychological impairment after hemorrhagic stroke in basal ganglia

853

Neuropsychological impairment associated with compulsive hoarding

854

Neuropsychological impairment in fibromyalgia: Relation to depression, fatigue, and pain

855

Neuropsychological information in the Wechsler adult intelligence scale—revised

856

Neuropsychological Interventions: Clinical Practice and Research: By Paul J. Eslinger. New York: The Guilford Press, 2002, 359 pages

857

Neuropsychological Manifestation in Ebola: A Concern

858

Neuropsychological measures probably facilitate heritability research of ADHD

859

Neuropsychological outcome and quantitative neuroimaging in mild head injury,

860

Neuropsychological Outcome and the Extent of Resection in the Unilateral Temporal Lobectomy

861

Neuropsychological outcome following focal cortical removal for intractable epilepsy in children

862

Neuropsychological Outcome following Resuscitation after Out-of-Hospital Cardiac Arrest: A One-Year Follow-Up

863

Neuropsychological Outcome in Children after Frontal Lobe Epilepsy Surgery

864

Neuropsychological Outcome of Head Injury Using a Short Battery

865

NEUROPSYCHOLOGICAL OUTCOMES OF NOCTURNAL ASTHMA

866

Neuropsychological outcomes of pediatric burn patients who sustained hypoxic episodes

867

Neuropsychological parameters of pediatric migraineurs and tensioneurs

868

Neuropsychological performance deficits in adults with attention deficit/hyperactivity disorder

869

Neuropsychological performance in a sample of 13–25 year olds with a history of non-psychotic major depressive disorder

870

Neuropsychological performance in adult attention-deficit hyperactivity disorder: Meta-analysis of empirical data

871

Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: A longitudinal, naturalistic study

872

Neuropsychological Performance in Children and Adolescents with Obsessive-Compulsive Disorder and Influence of Clinical Variables

873

Neuropsychological Performance in First-Episode Adolescents with Schizophrenia: A Comparison with First-Episode Adults and Adolescent Control Subjects

874

Neuropsychological performance in gravesʹ hyperthyroidism: Evidence for executive dysfunction

875

Neuropsychological Performance in Gulf War Era Veterans: Motivational Factors and Effort

876

Neuropsychological Performance in Gulf War Era Veterans: Neuropsychological Symptom Reporting

877

Neuropsychological Performance in Gulf War Era Veterans: Traumatic Stress Symptomatology and Exposure to Chemical–Biological Warfare Agents

878

Neuropsychological performance in men and women at risk for hypertension

879

Neuropsychological performance in normal pregnancy and preeclampsia

880

Neuropsychological performance in pediatric bipolar disorder

881

Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity

882

Neuropsychological performance of a clinical sample of extremely obese individuals

883

Neuropsychological Performance of Adults Evidencing Attention-Deficit Hyperactivity Disorder

884

Neuropsychological performance of monozygotic twins discordant for bipolar disorder

885

Neuropsychological Performance Over Time in People at High Risk of Developing Schizophrenia and Controls

886

Neuropsychological performance predicts clinical recovery in bipolar patients

887

Neuropsychological predictors of adaptive living and work behaviors

888

Neuropsychological predictors of emotional prosody: Implications for hemispheric asymmetry

889

Neuropsychological Profile at Three Months Post Injury in Patients with Traumatic Brain Injury

890

Neuropsychological profile in patients with obsessive-compulsive disorder over a period of 4-month treatment

891

Neuropsychological Profile of a Large Kindred with Familial Alzheimerʹs Disease Caused by the E280A Single Presenilin-1 Mutation

892

Neuropsychological profile of patients with juvenile myoclonic epilepsy: A controlled study of 50 patients

893

Neuropsychological profile of prodromal Alzheimerʹs disease (Prd-AD) and their radiological correlates

894

Neuropsychological Profiles Associated with Subcortical White Matter Alterations and Parkinsonʹs Disease:: Implications for the Diagnosis of Dementia

895

Neuropsychological profiles of children diagnosed as specific language impaired with and without hyperlexia

896

Neuropsychological recovery from childhood moyamoya disease

897

Neuropsychological Sequelae in a Series of Patients with End-Stage Cystic Fibrosis: Lung Transplant Evaluation

898

Neuropsychological sequelae in subacute home chlordane poisoning: Ten case studies

899

Neuropsychological Similarities and Differences Among Huntington’s Disease, Multiple Sclerosis, and Cortical Dementia

900

Neuropsychological Studies of Late Onset and Subthreshold Diagnoses of Adult Attention-Deficit/Hyperactivity Disorder

901

Neuropsychological study of ciguatera fish poisoning: A longitudinal case-control study

902

Neuropsychological Test Development and Normative Data on Hispanics

903

Neuropsychological test performance and prediction of functional capacities among Spanish-speaking and English-speaking patients with dementia

904

Neuropsychological test performance in a cognitively intact sample of older Japanese American adults

905

Neuropsychological Test Performance in Illiterate Subjects

906

Neuropsychological test performance of children with ADHD relative to test norms and parent behavioral ratings

907

Neuropsychological Test Performances of Young Depressed Outpatient Women: An Examination of Executive Functions

908

Neuropsychological testing defines the neurobehavioral significance of neuroimaging-identified abnormalities

909

Neuropsychological testing of adults: further considerations for neurologists

910

Neuropsychological testing of high school athletes: Preliminary norms and test–retest indices

911

Neuropsychological tests and SPECT in dementing disorders

912

Neuropsychological tests predict independent activities of daily living in patients with dementia

913

Neuropsychological toxicology: Identification and assessment of human neurotoxic syndromes : Second Edition, by David E. Hartman. New York: Plenum Press, 1995. 429 pp, $59.50 hardcover

914

Neuropsychological, Neuroanatomical, and Neurophysiological Consequences of CNS Chemotherapy for Acute Lymphoblastic Leukemia

915

Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia

916

Neuropsychologistsʹ Practice Patterns in Assessing Premorbid Intelligence

917

Neuropsychologists’ abilities to determine the predictive value of diagnostic tests

918

Neuropsychology and linguistic aphasiology: Evidence in favor of case studies

919

Neuropsychology is nothing without control: A potential fallacy hidden in clinical studies

920

Neuropsychology of Alzheimerʹs Disease

921

Neuropsychology of bipolar disorder: a review

922

Neuropsychology of BPI and BPII

923

Neuropsychology of BPI and BPII

924

Neuropsychology of BPI and BPII

925

Neuropsychology of developmental stuttering

926

Neuropsychology of dual diagnosis: Understanding the combined effects of schizophrenia and substance use disorders

927

Neuropsychology of obsessive-compulsive disorder: a review and treatment implications

928

Neuropsychology of timing and time perception

929

Neuropsychology, the Patientʹs Experience, and the Political Forces Within Our Field

930

Neuroptera in agricultural ecosystems

931

Neuropteran (Insecta) palaeodiversity with predictions for the Cretaceous fauna of the Wealden

932

Neuroradiologic MR applications with multiparametric color composite display

933

Neuroradiological assessment of brain structure and function and its implication in the pathogenesis of West syndrome

934

Neuroradiological findings in primary cerebral lymphomas of non-AIDS patients

935

Neuroradiology of spine degenerative diseases

936

Neuroreceptor subunit genes and the genetic susceptibility to gilles de la tourette syndrome

937

Neurorehabilitation, the Practical Method of Returning to Work after Stroke

938

Neurorehabilitation: no more constraint for large randomised trials

939

Neuroretinal function is normal in early dementia of the Alzheimer type

940

Neurosarcoidosis

941

Neurosarcoidosis presenting as a large suprasellar mass: Magnetic resonance imaging findings

942

Neurosarcoidosis presenting with simple partial seizures and solitary enhancing mass: case reports and review of the literature

943

Neurosarcoidosis: a clinical dilemma

944

Neurosarcoidosis: a treatable cause of vestibular dysfunction

945

Neurosarcoidosis: Findings in MRI

946

Neuroscience and computing algorithms

947

Neuroscience and the soul: Competing explanations for the human experience

948

Neuroscience approach in Stem cell therapy among patients with Spinal Cord Injury

949

Neuroscience as an Insightful Decision Support Tool for Sustainable Development

950

Neuroscience meets dance/movement therapy: Mirror neurons, the therapeutic process and empathy

951

Neuroscience output of China: A MEDLINE-based bibliometric study

952

Neuroscience research on the addictions: A prospectus for future ethical and policy analysis

953

Neuroscience, neuroimaging and the law

954

Neuroscience, quantum indeterminism and the Cartesian soul

955

Neuroscience: Where is it heading?: Some reflections on the future of brain research at the end of the second millenium

956

Neuroscience-Informed Psychoeducation for Recovery: A Program to Promote Metacognition in People With Substance Use Disorders

957

Neurosciences Quiz: Subclinical rhythmic electrographic discharges of adults (SREDA): Case Presentation

958

Neurosciences, psychiatrie et psychopathologie : quelles évolutions pour la relation clinique ?

959

Neuroscientific challenges to free will and responsibility

960

Neuroscientists discover disgusting regions of the brain

961

Neuroscientists hear impassioned plea from Superman

962

Neuroscientists take a BOLD step forward

963

Neuro-Second Order Sliding Mode Control of a DFIG Supplied by a Two-Level NSVM Inverter for Wind Turbine System

964

Neurosensory changes of palatal mucousa following Le Fort I osteotomy

965

Neuro-short-term load forecast of the power system in Kuwait

966

Neuro-simulation analysis of pressure maintenance operations in gas condensate reservoirs

967

Neuro-simulation modeling of chemical flooding

968

Neurosolver: Neuromorphic general problem solver

969

Neurosphere-Free Transdifferentiation of Rat Bone Marrow Stromal Stem Cells Into Retinal Cells and Retinal Pigment Epithelium

970

Neurospora crassa CyPBP37: A Cytosolic Stress Protein that is able to Replace Yeast Thi4p Function in the Synthesis of Vitamin B1

971

Neurospora crassa FKBP22 Is a Novel ER Chaperone and Functionally Cooperates with BiP

972

Neurosteroid analogues. Part 13: Synthetic methods for the preparation of 2β-hydroxygonane derivatives as structural mimics of ent-3α-hydroxysteroid modulators of GABAA receptors

973

Neurosteroid analogues: synthesis of 6-aza-allopregnanolone

974

Neurosteroid analysis by gas chromatography–atmospheric pressure photoionization–tandem mass spectrometry Original Research Article

975

Neurosteroid dehydroepiandrosterone attenuates 6-hydroxydopamine-induced apoptosis in a cell model of Parkinson's disease

976

Neurosteroids in Rat Brain: Extraction, Isolation, and Analysis by Nanoscale Liquid Chromatography-Electrospray Mass Spectrometry

977

Neurosteroids: 7-aza-allopregnanolone—a poor substitute for allopregnanolone

978

Neurostimulation as a Putative Method for the Treatment of Drug-resistant Epilepsy in Patient and Animal Models of Epilepsy

979

Neurosurgeons report gains in treatment of vascular malformations

980

Neurosurgeons wake up to awake-brain surgery

981

Neurosurgery 7000 years ago in central Italy

982

Neurosurgery in a cold climate

983

Neurosurgery Practice During the COVID-19 Pandemic

984

Neurosurgical Approaches in Demyelinating Disorders; Where are We Now?

985

Neurosurgical Care of Nonpowder Firearm Injuries: A Narrative Review of the Literature

986

Neurosurgical Development in the East, Central and Southern African (ECSA) Region

987

Neurosurgical emergencies, volumes I and II : Christopher Loftus, MD, editor. American Association of Neurological Surgeons, 1994

988

Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: Experience from the GUSTO-I Trial, , , ,

989

NEUROSURGICAL IN-PATIENT PROFILE:A THREE-YEAR AUDIT IN A REGIONAL CENTRE

990

Neurosurgical management of pain: by Richard B. North and Robert M. Levy, Springer Verlag, New York, 1997, ISBN 0-387-94256-4

991

Neurosurgical Operating Room Nurse’s Roles and Responsibilities

992

Neurosurgical procedures for refractory OCD

993

Neurosurgical Procedures in Jehovah’s Witnesses: The Tema Experience

994

Neurosurgical treatment for Gilles de la Tourette syndrome: The Italian perspective

995

Neurosyphilis presenting as refractory status epilepticus

996

Neurosyphilis with Hydrocephalus: A Case Report

997

Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders

998

NeuroTheology and Its Convergence with NeuroQuantology

999

Neurotheology: The relationship between brain and religion.

1000

Neurotic butterflies in my stomach: The role of anxiety, anxiety sensitivity and depression in functional gastrointestinal disorders

بازگشت